Induction of a physical linkage between integrins and the cytoskeleton depends on intracellular calcium in an epithelial cell line.
In most cases epithelial cells reveal a polarized distribution of integrin receptors in basolateral domains of the plasma membrane. To evaluate the functional state of integrin receptors in these restricted sites we were interested in the physical association of integrins with the cytoskeleton. Basically, we extracted cells with Triton X-100 to obtain detergent insoluble cytoskeleton fractions and used monoclonal antibodies for the detection of integrins linked to the cytoskeleton. We found that no permanent physical integrin-cytoskeleton associations exist in a confluent culture of the hepatocyte cell line mHepR1. However, incubation with anti-integrin antibodies and cross linking with a secondary antibody induced a physical linkage of beta1 as well as of different alpha subunits to the cytoskeleton. The association of integrins with the cytoskeleton was also inducible in suspended cells, which was detected in flow cytometric analyses and indicates that the formation of a physical integrin-cytoskeleton connection is independent of the localization of integrins, cell shape, and adhesion on a substrate. Using the Ca2+ chelators BAPTA-AM and EGTA, we found that intracellular calcium is a necessary prerequisite to induce a connection of integrins to the cytoskeleton. ATP or tauroursodeoxycholic acid, which provoke an intracellular calcium elevation, partly induced the formation of an integrin-cytoskeleton linkage. These results indicate the obvious role of intracellular calcium in integrin-dependent outside-in as well as inside-out signaling.
Nebe
B
B
Department of Internal Medicine, University of Rostock, Germany.
Bohn
W
W
Sanftleben
H
H
Rychly
J
J
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000378:metabolism*; D002458:Cell Fractionation; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism / Q000648:ultrastructure; D002614:Chelating Agents / Q000494:pharmacology; D003432:Cross-Linking Reagents; D003599:Cytoskeleton / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D004533:Egtazic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D004848:Epithelium; D005434:Flow Cytometry; D016023:Integrins / Q000096:biosynthesis / Q000187:drug effects / Q000378:metabolism*; D008099:Liver; D051379:Mice; D008854:Microscopy, Electron; D017830:Octoxynol; D011485:Protein Binding; D013655:Taurochenodeoxycholic Acid / Q000494:pharmacology
D002614:Chelating Agents; D003432:Cross-Linking Reagents; D016023:Integrins; C070379:1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester; D013655:Taurochenodeoxycholic Acid; D004533:Egtazic Acid; C031655:ursodoxicoltaurine; D000255:Adenosine Triphosphate; D017830:Octoxynol; D002118:Calcium